Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells.

Saved in:
Bibliographic Details
Title: Transcriptomic Analysis Reveals an NRF2-Mediated Redox and Metabolic Reprogramming in Sorafenib-Resistant Hepatocellular Carcinoma Cells.
Authors: Michilli A; Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy., Bassi C; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.; Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), University of Ferrara, 44121 Ferrara, Italy., Moshiri F; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy., De Siena B; Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy., Marinaro R; Center for Molecular Biology (CDBM), Ferrara University Hospital, 44124 Ferrara, Italy., Callegari E; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy., Negrini M; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.; Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), University of Ferrara, 44121 Ferrara, Italy.; Center for Molecular Biology (CDBM), Ferrara University Hospital, 44124 Ferrara, Italy., Sabbioni S; Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.; Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA), University of Ferrara, 44121 Ferrara, Italy.
Source: Biotech (Basel (Switzerland)) [BioTech (Basel)] 2026 Feb 11; Vol. 15 (1). Date of Electronic Publication: 2026 Feb 11.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 9918383086206676 Publication Model: Electronic Cited Medium: Internet ISSN: 2673-6284 (Electronic) Linking ISSN: 26736284 NLM ISO Abbreviation: BioTech (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2673-6284
DOI:10.3390/biotech15010018